Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wally R Smith

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Southern Medical Journal|March 5, 2019
Lessons Learned from Building a Pediatric-to-Adult Sickle Cell Transition ProgramWally R Smith, India Y Sisler, Shirley Johnson, et al.
Journal of the National Medical Association|February 17, 2005
Understanding pain and improving management of sickle cell disease: the PiSCES studyWally R Smith, Viktor E Bovbjerg, Lynne T Penberthy, et al.
Annals of Internal Medicine|January 16, 2008
Daily assessment of pain in adults with sickle cell diseaseWally R Smith, Lynne T Penberthy, Viktor E Bovbjerg, et al.
The Journal of Pain|December 23, 2018
AAAPT Diagnostic Criteria for Acute Sickle Cell Disease PainJoshua J Field, Samir K Ballas, Claudia M Campbell, et al.
Pain|July 28, 2009
Pain site frequency and location in sickle cell disease: the PiSCES projectDonna K McClish, Wally R Smith, Bassam A Dahman, et al.
British Journal of Haematology|February 18, 2011
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043)Kenneth I Ataga, Marvin Reid, Samir K Ballas, et al.
Blood|January 15, 2008
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemiaKenneth I Ataga, Wally R Smith, Laura M De Castro, et al.
Blood|March 4, 2015
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid useMarilyn J Telen, Ted Wun, Timothy L McCavit, et al.
Psychosomatic Medicine|December 26, 2007
Depression and anxiety in adults with sickle cell disease: the PiSCES projectJames L Levenson, Donna K McClish, Bassam A Dahman, et al.
Journal of Opioid Management|May 20, 2015
Daily home opioid use in adults with sickle cell disease: The PiSCES projectWally R Smith, Donna K McClish, Bassam A Dahman, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Southern Medical Journal|March 5, 2019
Lessons Learned from Building a Pediatric-to-Adult Sickle Cell Transition ProgramWally R Smith, India Y Sisler, Shirley Johnson, et al.
Journal of the National Medical Association|February 17, 2005
Understanding pain and improving management of sickle cell disease: the PiSCES studyWally R Smith, Viktor E Bovbjerg, Lynne T Penberthy, et al.
Annals of Internal Medicine|January 16, 2008
Daily assessment of pain in adults with sickle cell diseaseWally R Smith, Lynne T Penberthy, Viktor E Bovbjerg, et al.
The Journal of Pain|December 23, 2018
AAAPT Diagnostic Criteria for Acute Sickle Cell Disease PainJoshua J Field, Samir K Ballas, Claudia M Campbell, et al.
Pain|July 28, 2009
Pain site frequency and location in sickle cell disease: the PiSCES projectDonna K McClish, Wally R Smith, Bassam A Dahman, et al.
British Journal of Haematology|February 18, 2011
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043)Kenneth I Ataga, Marvin Reid, Samir K Ballas, et al.
Blood|January 15, 2008
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemiaKenneth I Ataga, Wally R Smith, Laura M De Castro, et al.
Blood|March 4, 2015
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid useMarilyn J Telen, Ted Wun, Timothy L McCavit, et al.
Psychosomatic Medicine|December 26, 2007
Depression and anxiety in adults with sickle cell disease: the PiSCES projectJames L Levenson, Donna K McClish, Bassam A Dahman, et al.
Journal of Opioid Management|May 20, 2015
Daily home opioid use in adults with sickle cell disease: The PiSCES projectWally R Smith, Donna K McClish, Bassam A Dahman, et al.
Pageof 10